Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-κB activation

American Journal of Pathology

Volumn 150, Issue 6, 1997, Pages 2019-2031

  Kilgore, Kenneth S ^a   Schmidt, Elisabeth ^c   Shanley, Thomas P ^a   Flory, Craig M ^b   Maheswari, Vipul ^a   Tramontini, Nicole L ^a   Cohen, Hillary ^a   Ward, Peter A ^a   Friedl, Hans P ^c   Warren, Jeffrey S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Pharmaceutical Research Divsion   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; COMPLEMENT MEMBRANE ATTACK COMPLEX; DITHIOCARBAMIC ACID DERIVATIVE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDE;

ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DNA BINDING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; CHEMOKINE CCL2; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYTOSOL; DNA; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; NF-KAPPA B; PYRROLIDINES; THIOCARBAMATES; TIME FACTORS; UMBILICAL VEINS;

EID: 17944384904     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 1994, 84:2068-2085
2. Hugli RE: The chemistry and biology of C3a, C4a and C5a and their effects on cell. Biological Response Mediators and Modulators. Edited by JT August. New York, Academic Press, 1983, pp 99-116
3. Nicholson-Weller A, Halperin JA: Membrane signaling by complement C5b-9, the membrane attack complex. Immunol Res 1993, 12:244-257
4. Asghar SS: Biology of disease: membrane regulators of complement activation and their aberrant expression in disease. Lab Invest 1995, 72:254-271
5. Schonermark M, Deppisch R, Riedasch G, Rother GK, Mansch GM: Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9. Int Arch Allergy Appl Immunol 1991, 96:331-337
6. Lovett D, Hansch GM, Resch K, Gemsa D: Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol 1987, 138: 2473-2479
7. Benzaquen LR, Nicholson-Weller A, Halperin JA: Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J Exp Med 1994, 179:985-992
8. Kilgore KS, Flory CM, Miller BF, Evans VM, Warren JS: The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am J Pathol 1996, 149:953-961
9. Torzewski J, Oldroyd R, Lachmann P, Fitzsimmons C, Proudfoot D, Bowyer D: Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. Arterioscler Thromb Vasc Biol 1996, 16: 673-677
10. Niculescu F, Rus H, Shin ML: Receptor-independent activation of guanine nucleotide-binding regulatory proteins by terminal complement complexes. J Biol Chem 1994, 269:4417-4423
11. Carney DF, Lang TJ, Shin ML: Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. J Immunol 1990, 45:623-629
12. 2+-initiated activation of cellular protein kinases. J Biol Chem 1987, 262:13674-13681
13. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T: Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 1995, 9:899-909
14. Collins T: Biology of disease: endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest 1993, 68:499-508
15. Hou J, Baichwal V, Cao Z: Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding ICAM-1. Proc Natl Acad Sci USA 1994, 91:1641-11645
16. Jahnke A, Johnson JP: Synergistic activation of intercellular adhesion molecule-1 (ICAM-1) by TNF-α and IFN-γ is mediatied by p65/p50 and p65/c-Rel and interferon-responsive factor Stat 1-α (p91) that can be activated by both IFN-γ and INF-α, FEBS Lett 1994, 354:220-226
17. Parry GC, Mackman N: A set of inducible genes expressed by activated human monocytic and endothelial cells contain κB-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem 1994, 269: 20823-20825
18. Pober JS, Cotran RC: Cytokines and endothelial cell biology. Physiol Rev 1990, 70:427-451
19. Baeuerle PA: The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim Biophys Acta 1991, 107:63-80
20. Lenard MJ, Baltimore D. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1988, 7:318-332
21. Zabel U, Baeuerle PA: Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 1990, 61:255-265
22. Finco TS, Beg AA, Baldwin AS: Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc Natl Acad Sci USA 1994, 91:11884-11888
23. Miyamoto S, Maki M, Schmitt MJ, Hatanaka M, Verma IM: Tumor necrosis factor α-induced phosphorylation of IκBα is a signal for its degradation but not dissociation from NF-κB. Proc Natl Acad Sci USA 1994, 91: 12740-12744
24. Lin Y-Z, Yao SY, Veach RA, Torgerson TR, Hawiger J: Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995, 270:14255-14258
25. Jaffe EA: Culture and identification of large vessel endothelial cells. Biology of Endothelial Cells. Edited by EA Jaffe. The Hague, Martinus Nijoff, p 13
26. Vogt W, Hesse D: Activation of the fifth component of human complement by oxygen-derived free radicals, and by methionine oxidizing agents: a comparison. Immunobiology 1992, 184:384-391
27. Vogt W, Zimmerman B, Hesse D, Nolte R: Activation of the fifth component of human complement, C5, without cleavage, by methionine oxidizing agents. Mol Immunol 1992, 29:251-256
28. Kilgore KS, Shen JP, Miller BF, Ward PA, Warren JS: Enhancement by the complement membrane attack complex of tumor necrosis factor-α induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 1995, 155:1434-1441
29. Kravchenko VV, Pan, Z, Han J, Herbert JM, Ulevitch RJ, Ye RD: Platelet-activating factor induces NF-κB activation through a G protein-coupled pathway. J Biol Chem 1995, 270:14928-14934
30. Menon SD, Qin S, Guy GR, Tan YH: Differential induction of nuclear NF-κB by protein phosphatase inhibitors in primary and transformed human cells. J Biol Chem 1993, 268:26806-26812
31. Molitor JA, Walker WH, Doerre S, Ballard DW, Greene WC. NF-κB: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc Natl Acad Sci USA 1990, 87:10028-10032
32. Osborn K, Kunkel S, Nabel GJ: Tumor necrosis factor and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of nuclear κB. Proc Natl Acad Sci USA 1989, 86:2336-2340
33. Schreck R, Meier B, Mannel DM, Drogew W, Baeuerle PA: Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med 1992 175:1181-1194
34. Hattori R, Hamilton KK, Fugate RD, McEver RP, Sims PJ: Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989, 264:7768-7771
35. Hattori R, Hamilton, KK, McEver RP, Sims PJ: Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 1989, 264: 9053-9060
36. Adler S, Baker PJ, Johnson RJ, Ochi F, Pritzi P, Couser WG: Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest 1986, 77:762-767
37. Baeuerle PA, Baltimore D: Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 1988, 53:211-217
38. Hirano M, Hirai S, Mizuno K, Osada S, Hosaka M, Ohno S: A protein kinase C isozyme nPKC∈ is involved in the activation of NF-κB by 12-O-tetradecanoylphorbol-13-acetate (TPA) in rat 3Y1 fibroblasts. J Biol Chem 1995, 206:429-436
39. Acosta JA, Benzaquen LR, Goldstein DJ, Tosteson MT, Halperin JA: The transient pore formed by homologous terminal complement complexes functions as a bidirectional route for the transport of autocrine and paracrine signals across human cell membranes. Mol Med 1996, 2:755-765
40. Read MA, Whitley MZ, Williams AJ, Collins T: NF-κB and IκBα: an inducible regulatory system in endothelial activation. J Exp Med 1994, 179:503-512
41. Isral N, Gougerot-Pocidalo MA, Aillet F, Virelizier JL: Redox status of cells influences constitutive or induced NF-κB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J Immunol 1992, 149:3386-3393
42. Staal JT, Roederer M, Herzenberg LA, Herzenberg LA: Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990, 87:9943-9947
43. Meichle A, Schutze S, Hensel G, Brunsing D, Kronke M: Protein kinase C-independent activation of nuclear transcription factor κB by tumor necrosis factor. J Biol Chem 1990, 265:8339-8343
44. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB and transcription factor and HIV-1. EMBO J 1991, 10:2247-2258
45. Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW: Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 1991, 3:189-194
46. Metinko AP, Kunkel SL, Standiford TJ, Strieter RM: Anoxia-hyperoxia induces monocyte-derived interleukin-8. J Clin Invest 1992, 90:791-798
47. Satriano JA, Shuldiner, Hora MK, Xing Y, Shan Z, Schlondorff D: Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein JE/MCP-1 and the monocyte colony-stimulating factor CSF-1 in response to tumor necrosis factor-α and immunoglobulin G. J Clin Invest 1993, 92:1564-1571
48. DeForge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, Remick DG: Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem 1993, 268: 25568-25576